Brad Kahl

Dr. Kahl is an associate professor of medicine at the University of Wisconsin School of Medicine and Public Health. He is the director of the UW Lymphoma Service and clinical research director for hematologic malignancies at the Paul P. Carbone Comprehensive Cancer Center. He received his medical degree from Tufts University where he was elected AOA. He completed all post-graduate training at the University of Wisconsin and was appointed to the faculty in 2000.

His clinical interests involve the care of patients with Hodgkin lymphoma, non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia.

His research focuses on the development of new treatments for lymphoma patients, with emphasis on novel agents. Particular areas of interest include Mantle Cell Lymphoma and Follicular Lymphoma. He is the principle investigator of numerous clinic trials, including phase I, phase II, and phase III at Washington University. He is also the Chairman of the Eastern Cooperative Oncology Group Lymphoma Committee and oversees all research performed by this organization.